Geftirosa 250mg Tablet 10s

Introduction to Geftirosa 250mg Tablet 10s

Geftirosa 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer has certain genetic mutations called EGFR mutations. This medicine is often prescribed to patients who have not undergone chemotherapy before.

Composition of Geftirosa 250mg Tablet 10s

The active ingredient in Geftirosa 250mg Tablet is Gefitinib. This component is crucial in targeting and inhibiting cancer cell growth.

Uses of Geftirosa 250mg Tablet 10s

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancers with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftirosa 250mg Tablet 10s

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftirosa 250mg Tablet 10s

Geftirosa should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftirosa 250mg Tablet 10s

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Follow your healthcare provider's instructions carefully.

Conclusion of Geftirosa 250mg Tablet 10s

Geftirosa 250mg Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.